tamoxifen
Not Tagged
['bcsm', 'ovarian', 'tamoxi']
ebctg meta-analysis: ovarian suppression/ablation
15,000 women
if no chemo or premenopausal after chemo: *29% reduced recurrence, more benefit over time
*no significant effect of age
*improved survival
*less benefit if received tamoxifen richard gray #bcsm #asco23 
Medical oncologist @Intermountain, Director of Breast Oncology. Clinical research, quality improvement, cardio-oncology, provider wellness. All tweets my own.